LifeCycle Pharma Appoints Dr. Claus Braestrup And Dr. Gérard Soula As New Board Members

San Francisco, March 21 (By Suvarna Bhatt, BioSpace) - Hørsholm, Denmark based LifeCycle Pharma, announces the appointment of Dr. Claus Braestrup, President and CEO of Lundbeck A/S and Dr. Gérard Soula founder and former President and CEO of Flamel Technologies S.A. as new members of its Board of Directors. The executive appointments will lead the company into commercialization and marketing of its products, one of which the company expects to bring to the market in 2007.
MORE ON THIS TOPIC